APO Research
Talk to an analyst

APO RESEARCH · REPORT

Infectious Disease Telehealth

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Infectious Disease Telehealth Market Outlook and Growth Opportunities 2026

15 January 2026195 pages

Choose your research edition.

Industry ResearchInfectious Disease Telehealth Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Infectious Disease Telehealth Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Infectious Disease Telehealth Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Infectious Disease Telehealth Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Infectious Disease Telehealth Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Infectious Disease Telehealth market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Infectious Disease Telehealth is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Infectious Disease Telehealth is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Infectious Disease Telehealth is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Infectious Disease Telehealth market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Infectious Disease Telehealth market include Teladoc Health, Inc., Amwell (American Well Corporation), MDLIVE, Doctor On Demand, HealthTap, Infectious Disease Connect, Alina Telehealth, WELL Health Technologies and Allscripts, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Infectious Disease Telehealth market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Infectious Disease Telehealth and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Infectious Disease Telehealth revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Infectious Disease Telehealth market.

Infectious Disease Telehealth Segment by Company

Teladoc Health, Inc.

Amwell (American Well Corporation)

MDLIVE

Doctor On Demand

HealthTap

Infectious Disease Connect

Alina Telehealth

WELL Health Technologies

Allscripts

AMD Global Telemedicine Inc.

Infectious Disease Telehealth Segment by Type

Video-Based Platforms

Mobile App-Based Services

Web-Based Portals

AI-Enabled Decision Support Systems

Infectious Disease Telehealth Segment by Application

Hospitals and Health Systems

Clinics and Outpatient Centers

Public Health Agencies

Employers and Insurers

Home-Based Patients

Infectious Disease Telehealth Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Infectious Disease Telehealth status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Infectious Disease Telehealth key companies, revenue, market share, and recent developments.

3. To split the Infectious Disease Telehealth breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Infectious Disease Telehealth market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Infectious Disease Telehealth significant trends, drivers, influence factors in global and regions.

6. To analyze Infectious Disease Telehealth competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Infectious Disease Telehealth market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Infectious Disease Telehealth and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Infectious Disease Telehealth.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Infectious Disease Telehealth industry.

Chapter 3: Detailed analysis of Infectious Disease Telehealth company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Infectious Disease Telehealth in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Infectious Disease Telehealth in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Infectious Disease Telehealth Industry Trends Table 2. Infectious Disease Telehealth Industry Drivers Table 3. Infectious Disease Telehealth Industry Opportunities and Challenges Table 4. Infectious Disease Telehealth Industry Restraints Table 5. Global Infectious Disease Telehealth Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Infectious Disease Telehealth Revenue Share by Company (2021-2026) Table 7. Global Infectious Disease Telehealth Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Infectious Disease Telehealth Key Company Manufacturing Base & Headquarters Table 9. Global Infectious Disease Telehealth Company, Product Type & Application Table 10. Global Infectious Disease Telehealth Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Infectious Disease Telehealth by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Video-Based Platforms Table 15. Significant Companies of Mobile App-Based Services Table 16. Significant Companies of Web-Based Portals Table 17. Significant Companies of AI-Enabled Decision Support Systems Table 18. Global Infectious Disease Telehealth Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Infectious Disease Telehealth Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Infectious Disease Telehealth Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Infectious Disease Telehealth Sales Value Share by Type (2021-2026) Table 22. Global Infectious Disease Telehealth Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Hospitals and Health Systems Table 24. Significant Companies of Clinics and Outpatient Centers Table 25. Significant Companies of Public Health Agencies Table 26. Significant Companies of Employers and Insurers Table 27. Significant Companies of Home-Based Patients Table 28. Global Infectious Disease Telehealth Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Infectious Disease Telehealth Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Infectious Disease Telehealth Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Infectious Disease Telehealth Sales Value Share by Application (2021-2026) Table 32. Global Infectious Disease Telehealth Sales Value Share by Application (2027-2032) Table 33. Global Infectious Disease Telehealth Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Infectious Disease Telehealth Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Infectious Disease Telehealth Sales Value Share by Region (2021-2026) Table 36. Global Infectious Disease Telehealth Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Infectious Disease Telehealth Sales Value Share by Region (2027-2032) Table 38. Global Infectious Disease Telehealth Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Infectious Disease Telehealth Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Infectious Disease Telehealth Sales Value Market Share by Country (2021-2026) Table 41. Global Infectious Disease Telehealth Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Infectious Disease Telehealth Sales Value Market Share by Country (2027-2032) Table 43. Teladoc Health, Inc. Company Information Table 44. Teladoc Health, Inc. Business Overview Table 45. Teladoc Health, Inc. Infectious Disease Telehealth Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Teladoc Health, Inc. Infectious Disease Telehealth Product Portfolio Table 47. Teladoc Health, Inc. Recent Development Table 48. Amwell (American Well Corporation) Company Information Table 49. Amwell (American Well Corporation) Business Overview Table 50. Amwell (American Well Corporation) Infectious Disease Telehealth Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Amwell (American Well Corporation) Infectious Disease Telehealth Product Portfolio Table 52. Amwell (American Well Corporation) Recent Development Table 53. MDLIVE Company Information Table 54. MDLIVE Business Overview Table 55. MDLIVE Infectious Disease Telehealth Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. MDLIVE Infectious Disease Telehealth Product Portfolio Table 57. MDLIVE Recent Development Table 58. Doctor On Demand Company Information Table 59. Doctor On Demand Business Overview Table 60. Doctor On Demand Infectious Disease Telehealth Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Doctor On Demand Infectious Disease Telehealth Product Portfolio Table 62. Doctor On Demand Recent Development Table 63. HealthTap Company Information Table 64. HealthTap Business Overview Table 65. HealthTap Infectious Disease Telehealth Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. HealthTap Infectious Disease Telehealth Product Portfolio Table 67. HealthTap Recent Development Table 68. Infectious Disease Connect Company Information Table 69. Infectious Disease Connect Business Overview Table 70. Infectious Disease Connect Infectious Disease Telehealth Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Infectious Disease Connect Infectious Disease Telehealth Product Portfolio Table 72. Infectious Disease Connect Recent Development Table 73. Alina Telehealth Company Information Table 74. Alina Telehealth Business Overview Table 75. Alina Telehealth Infectious Disease Telehealth Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Alina Telehealth Infectious Disease Telehealth Product Portfolio Table 77. Alina Telehealth Recent Development Table 78. WELL Health Technologies Company Information Table 79. WELL Health Technologies Business Overview Table 80. WELL Health Technologies Infectious Disease Telehealth Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. WELL Health Technologies Infectious Disease Telehealth Product Portfolio Table 82. WELL Health Technologies Recent Development Table 83. Allscripts Company Information Table 84. Allscripts Business Overview Table 85. Allscripts Infectious Disease Telehealth Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Allscripts Infectious Disease Telehealth Product Portfolio Table 87. Allscripts Recent Development Table 88. AMD Global Telemedicine Inc. Company Information Table 89. AMD Global Telemedicine Inc. Business Overview Table 90. AMD Global Telemedicine Inc. Infectious Disease Telehealth Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. AMD Global Telemedicine Inc. Infectious Disease Telehealth Product Portfolio Table 92. AMD Global Telemedicine Inc. Recent Development Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Infectious Disease Telehealth Product Image Figure 2. Global Infectious Disease Telehealth Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Infectious Disease Telehealth Market Size (2021-2032) & (US$ Million) Figure 4. Global Infectious Disease Telehealth Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Video-Based Platforms Image Figure 8. Mobile App-Based Services Image Figure 9. Web-Based Portals Image Figure 10. AI-Enabled Decision Support Systems Image Figure 11. Global Infectious Disease Telehealth Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Infectious Disease Telehealth Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Infectious Disease Telehealth Sales Value Share by Type (2021-2032) Figure 14. Hospitals and Health Systems Image Figure 15. Clinics and Outpatient Centers Image Figure 16. Public Health Agencies Image Figure 17. Employers and Insurers Image Figure 18. Home-Based Patients Image Figure 19. Global Infectious Disease Telehealth Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Infectious Disease Telehealth Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Infectious Disease Telehealth Sales Value Share by Application (2021-2032) Figure 22. Global Infectious Disease Telehealth Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Infectious Disease Telehealth Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Infectious Disease Telehealth Sales Value (2021-2032) & (US$ Million) Figure 25. North America Infectious Disease Telehealth Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Infectious Disease Telehealth Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Infectious Disease Telehealth Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Infectious Disease Telehealth Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Infectious Disease Telehealth Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Infectious Disease Telehealth Sales Value (2021-2032) & (US$ Million) Figure 31. South America Infectious Disease Telehealth Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Infectious Disease Telehealth Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Infectious Disease Telehealth Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Infectious Disease Telehealth Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Infectious Disease Telehealth Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Infectious Disease Telehealth Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Infectious Disease Telehealth Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Infectious Disease Telehealth Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Infectious Disease Telehealth Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Infectious Disease Telehealth Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Infectious Disease Telehealth Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Infectious Disease Telehealth Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Infectious Disease Telehealth Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Infectious Disease Telehealth Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Infectious Disease Telehealth Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Infectious Disease Telehealth Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Infectious Disease Telehealth Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Infectious Disease Telehealth Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Infectious Disease Telehealth Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Infectious Disease Telehealth Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Infectious Disease Telehealth Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Infectious Disease Telehealth Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Infectious Disease Telehealth Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Infectious Disease Telehealth Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Infectious Disease Telehealth Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Infectious Disease Telehealth Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Infectious Disease Telehealth Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Infectious Disease Telehealth Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Infectious Disease Telehealth Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Infectious Disease Telehealth Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Infectious Disease Telehealth Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Video-Based Platforms
  • Mobile App-Based Services
  • Web-Based Portals
  • AI-Enabled Decision Support Systems
Applications
  • Hospitals and Health Systems
  • Clinics and Outpatient Centers
  • Public Health Agencies
  • Employers and Insurers
  • Home-Based Patients
Companies covered
  • Teladoc Health, Inc.
  • Amwell (American Well Corporation)
  • MDLIVE
  • Doctor On Demand
  • HealthTap
  • Infectious Disease Connect
  • Alina Telehealth
  • WELL Health Technologies
  • Allscripts
  • AMD Global Telemedicine Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Infectious Disease Telehealth Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Infectious Disease Telehealth Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Infectious Disease Telehealth Market Dynamics
  1. 2.1 Infectious Disease Telehealth Industry Trends
  2. 2.2 Infectious Disease Telehealth Industry Drivers
  3. 2.3 Infectious Disease Telehealth Industry Opportunities and Challenges
  4. 2.4 Infectious Disease Telehealth Industry Restraints
3 Infectious Disease Telehealth Market by Company
  1. 3.1 Global Infectious Disease Telehealth Company Revenue Ranking in 2025
  2. 3.2 Global Infectious Disease Telehealth Revenue by Company (2021-2026)
  3. 3.3 Global Infectious Disease Telehealth Company Ranking (2024-2026)
  4. 3.4 Global Infectious Disease Telehealth Company Manufacturing Base and Headquarters
  5. 3.5 Global Infectious Disease Telehealth Company Product Type and Application
  6. 3.6 Global Infectious Disease Telehealth Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Infectious Disease Telehealth Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Infectious Disease Telehealth Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Infectious Disease Telehealth Market by Type
  1. 4.1 Infectious Disease Telehealth Type Introduction
  2. 4.1.1 Video-Based Platforms
  3. 4.1.2 Mobile App-Based Services
  4. 4.1.3 Web-Based Portals
  5. 4.1.4 AI-Enabled Decision Support Systems
  6. 4.2 Global Infectious Disease Telehealth Sales Value by Type
  7. 4.2.1 Global Infectious Disease Telehealth Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Infectious Disease Telehealth Sales Value by Type (2021-2032)
  9. 4.2.3 Global Infectious Disease Telehealth Sales Value Share by Type (2021-2032)
5 Infectious Disease Telehealth Market by Application
  1. 5.1 Infectious Disease Telehealth Application Introduction
  2. 5.1.1 Hospitals and Health Systems
  3. 5.1.2 Clinics and Outpatient Centers
  4. 5.1.3 Public Health Agencies
  5. 5.1.4 Employers and Insurers
  6. 5.1.5 Home-Based Patients
  7. 5.2 Global Infectious Disease Telehealth Sales Value by Application
  8. 5.2.1 Global Infectious Disease Telehealth Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Infectious Disease Telehealth Sales Value by Application (2021-2032)
  10. 5.2.3 Global Infectious Disease Telehealth Sales Value Share by Application (2021-2032)
6 Infectious Disease Telehealth Regional Value Analysis
  1. 6.1 Global Infectious Disease Telehealth Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Infectious Disease Telehealth Sales Value by Region (2021-2032)
  3. 6.2.1 Global Infectious Disease Telehealth Sales Value by Region: 2021-2026
  4. 6.2.2 Global Infectious Disease Telehealth Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Infectious Disease Telehealth Sales Value (2021-2032)
  7. 6.3.2 North America Infectious Disease Telehealth Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Infectious Disease Telehealth Sales Value (2021-2032)
  10. 6.4.2 Europe Infectious Disease Telehealth Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Infectious Disease Telehealth Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Infectious Disease Telehealth Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Infectious Disease Telehealth Sales Value (2021-2032)
  16. 6.6.2 South America Infectious Disease Telehealth Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Infectious Disease Telehealth Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Infectious Disease Telehealth Sales Value Share by Country, 2025 VS 2032
7 Infectious Disease Telehealth Country-level Value Analysis
  1. 7.1 Global Infectious Disease Telehealth Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Infectious Disease Telehealth Sales Value by Country (2021-2032)
  3. 7.2.1 Global Infectious Disease Telehealth Sales Value by Country (2021-2026)
  4. 7.2.2 Global Infectious Disease Telehealth Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Infectious Disease Telehealth Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Infectious Disease Telehealth Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Infectious Disease Telehealth Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Infectious Disease Telehealth Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Infectious Disease Telehealth Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Infectious Disease Telehealth Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Infectious Disease Telehealth Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Infectious Disease Telehealth Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Infectious Disease Telehealth Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Infectious Disease Telehealth Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Infectious Disease Telehealth Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Infectious Disease Telehealth Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Infectious Disease Telehealth Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Infectious Disease Telehealth Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Infectious Disease Telehealth Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Infectious Disease Telehealth Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Infectious Disease Telehealth Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Infectious Disease Telehealth Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Infectious Disease Telehealth Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Infectious Disease Telehealth Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Infectious Disease Telehealth Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Infectious Disease Telehealth Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Infectious Disease Telehealth Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Infectious Disease Telehealth Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Infectious Disease Telehealth Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Infectious Disease Telehealth Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Infectious Disease Telehealth Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Infectious Disease Telehealth Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Infectious Disease Telehealth Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Infectious Disease Telehealth Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teladoc Health, Inc.
  2. 8.1.1 Teladoc Health, Inc. Company Information
  3. 8.1.2 Teladoc Health, Inc. Business Overview
  4. 8.1.3 Teladoc Health, Inc. Infectious Disease Telehealth Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teladoc Health, Inc. Infectious Disease Telehealth Product Portfolio
  6. 8.1.5 Teladoc Health, Inc. Recent Developments
  7. 8.2 Amwell (American Well Corporation)
  8. 8.2.1 Amwell (American Well Corporation) Company Information
  9. 8.2.2 Amwell (American Well Corporation) Business Overview
  10. 8.2.3 Amwell (American Well Corporation) Infectious Disease Telehealth Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Amwell (American Well Corporation) Infectious Disease Telehealth Product Portfolio
  12. 8.2.5 Amwell (American Well Corporation) Recent Developments
  13. 8.3 MDLIVE
  14. 8.3.1 MDLIVE Company Information
  15. 8.3.2 MDLIVE Business Overview
  16. 8.3.3 MDLIVE Infectious Disease Telehealth Revenue and Gross Margin (2021-2026)
  17. 8.3.4 MDLIVE Infectious Disease Telehealth Product Portfolio
  18. 8.3.5 MDLIVE Recent Developments
  19. 8.4 Doctor On Demand
  20. 8.4.1 Doctor On Demand Company Information
  21. 8.4.2 Doctor On Demand Business Overview
  22. 8.4.3 Doctor On Demand Infectious Disease Telehealth Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Doctor On Demand Infectious Disease Telehealth Product Portfolio
  24. 8.4.5 Doctor On Demand Recent Developments
  25. 8.5 HealthTap
  26. 8.5.1 HealthTap Company Information
  27. 8.5.2 HealthTap Business Overview
  28. 8.5.3 HealthTap Infectious Disease Telehealth Revenue and Gross Margin (2021-2026)
  29. 8.5.4 HealthTap Infectious Disease Telehealth Product Portfolio
  30. 8.5.5 HealthTap Recent Developments
  31. 8.6 Infectious Disease Connect
  32. 8.6.1 Infectious Disease Connect Company Information
  33. 8.6.2 Infectious Disease Connect Business Overview
  34. 8.6.3 Infectious Disease Connect Infectious Disease Telehealth Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Infectious Disease Connect Infectious Disease Telehealth Product Portfolio
  36. 8.6.5 Infectious Disease Connect Recent Developments
  37. 8.7 Alina Telehealth
  38. 8.7.1 Alina Telehealth Company Information
  39. 8.7.2 Alina Telehealth Business Overview
  40. 8.7.3 Alina Telehealth Infectious Disease Telehealth Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Alina Telehealth Infectious Disease Telehealth Product Portfolio
  42. 8.7.5 Alina Telehealth Recent Developments
  43. 8.8 WELL Health Technologies
  44. 8.8.1 WELL Health Technologies Company Information
  45. 8.8.2 WELL Health Technologies Business Overview
  46. 8.8.3 WELL Health Technologies Infectious Disease Telehealth Revenue and Gross Margin (2021-2026)
  47. 8.8.4 WELL Health Technologies Infectious Disease Telehealth Product Portfolio
  48. 8.8.5 WELL Health Technologies Recent Developments
  49. 8.9 Allscripts
  50. 8.9.1 Allscripts Company Information
  51. 8.9.2 Allscripts Business Overview
  52. 8.9.3 Allscripts Infectious Disease Telehealth Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Allscripts Infectious Disease Telehealth Product Portfolio
  54. 8.9.5 Allscripts Recent Developments
  55. 8.10 AMD Global Telemedicine Inc.
  56. 8.10.1 AMD Global Telemedicine Inc. Company Information
  57. 8.10.2 AMD Global Telemedicine Inc. Business Overview
  58. 8.10.3 AMD Global Telemedicine Inc. Infectious Disease Telehealth Revenue and Gross Margin (2021-2026)
  59. 8.10.4 AMD Global Telemedicine Inc. Infectious Disease Telehealth Product Portfolio
  60. 8.10.5 AMD Global Telemedicine Inc. Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst